Summary
The localization and number of nucleoli of tumour nuclei were examined after conventional histological typing of breast carcinomas (WHO classification), staging, biochemical receptor status, and lectin binding site histochemistry. With increasing histological atypia and grade of malignancy, the frequency of nucleoli increased significantly and their location shifted from the center to the nuclear periphery. These changes correlated with an increase in indices of mitosis and cell loss. The nucleolar size correlated with the increase in the grade of malignancy. Hormone receptor and lectin binding site positive carcinomas were characterized by a low nucleolar frequency and by small nucleoli in central position, whereas carcinomas with high grades of malignancy and negative hormone receptor and lectin binding site status showed large, often multiple nucleoli in eccentricat position at a high frequency. The studies have demonstrated that nucleolar status is an easily practicable histological/cytological method for use in the assessment of prognosis of carcinomas of the breast.
Similar content being viewed by others
References
Azzopardi JG (1982) Problems in breast pathology. Vol 11: Major problems in pathology. Saunders Comp London Philadelphia Toronto
Barnard NY, Hall PA, Lemoine NR, Kadar N (1987) Proliferative index in breast carcinomata determined in situ by Ki 67 immunostaining and its relationship to clinical and pathological variables. J Pathol 152:287–295
Black MM, Asire MA (1969) Palpable axillary lymphnodes in cancer of the breast. Structural and biologic considerations. Cancer 23:251–259
Bloom HJG, Richardson WW (1957) Histological grading and prognosis in breast cancer: A study of 1409 cases of which 359 have been followed 15 years. Br J Cancer 11:359–377
Bondi A, Capucci A, Ghidoni D, Folicaldi S, Valmori V (1989) Nucleolar organizer region-associated proteins (AgNORs), hormone receptors and proliferating cells fraction in breast cancer. Pathol Res Pract 185:21
Crocker J, Nar P (1987) Nucleolar organizer regions in lymphomas. J Pathol 151:111–118
Crocker J, Skilbeck N (1987) Nucleolar organizer regions in melanocytic lesions: a quantitative study. J Clin Pathol 40:885–889
Dizerens P, Anani P, Gómez F, De Gani P (1985) Corrélations entre les récepteurs stéroidiens et la différenciation histopathologique des carcinomes mammaires chez la femme. J Gynecol Obstet Biol Reprod 14:843–859
Egan M J, Crocker J (1988) Nucleolar organizer regions in cutaneous tumors. J Pathol 154:247–253
Feichter GE, Müller A, Kaufmann M, Haag D, Born I, Kubli F, Goerttler K (1985) DNA - ploidy, DNA synthesis, histological grading, stage and steroid receptor content of breast cancer. Verh Dtsch Ges Pathol 69:143–144
Fisher ER, Sass R, Fisher B (1987) Pathologic findings from the national surgical adjuvant breast project. Correlations with concordant and discordant estrogen and progesterone receptors. Cancer 59:1554–1559
Franklin WA, Bibbo M, Doria MJ, Dytch HE, Tota J, Desombre E, Wild GL (1987) Quantitation of estrogen receptor content and Ki-67 staining in breast carcinoma by the Micro TICAS Image analysis system. Analyt Quant Cytol Histol 9:279–286
Gerdes J, Lelle RJ, Rickartz H, Heidenreich W, Schwarting R, Kurtsiefer L, Stauch G, Stein H (1986) Growth fractions in breast cancers determined in situ with monoclonal antibody Ki 67. J Clin Pathol 39:977–980
Guazzi A, Bozzetti C, Riva MI, Zaffe D, Cocconi G (1985) Relationship between estrogen receptor concentration and cytomorphometry in breast cancer. Cancer 56:1972–1976
Hall PA, Crocker J, Watts A, Stausfeld AG (1988) A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma. Histopathology 12:247–253
Helpap B (1988a) Frequency and localization of nucleoli in nuclei from prostatic carcinoma and atypical hyperplasia. Histopathology 13:203–211
Helpap B (1988b) Vergleich von Nukleolenstatus sowie Histologie, Grading und Hormonrezeptorstatus beim Mammakarzinom. Verh Dtsch Ges Pathol 72:595
Helpap B (1989) Pathologie der ableitenden Harnwege und der Prostata. Springer Verlag, Berlin Heidelberg New York London Paris Tokyo, pp 255–263
Hermanek P, Sobin LH (1987) TNM Classification of malignant tumours. Fourth, fully revised edition. Springer-Verlag, Berlin Heidelberg New York London Paris Tokyo
Klinga K, Kaufmann W, Runnebaum B, Kubli F (1982) Steroidhormonrezeptoren beim Mammakarzinom. Dtsch Med Wschr 107:313–315
Lee AK, Rosen PP, de Lellis RA, Saigo PE, Gangi MD, Groshen S, Bagin R, Wolfe HJ (1985) Tumor marker expression in breast carcinomas and relationship to prognosis. An immunohistochemical study. Am J Clin Pathol 84:687–696
Lelle RJ, Heidenreich W, Stauch G, Gerdes J (1987) The Correlation of growth factors with histological grading and lymph node status in human mammary carcinoma. Cancer 59:83–88
Lesser ML, Rosen PP, Senie RT, Duthie K, Menendez-Botet C, Schwartz MK (1981) Estrogen and progesterone receptors in breast carcinoma. Correlations with epidemiology and pathology. Cancer 48:299–309
Mattfeld T, Neurohr W, Müller A, Klinga K (1985) Morphometric correlates of steroid receptor content in invasive ductal breast cancer. Verh Dtsch Ges Pathol 69:350–355
McGurrin JF, Doria MI, Dawson PJ, Karrison Th, Stein HO, Franklin WA (1987) Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast. Cancer 59:1744–1750
Meyer JS, Hixton B (1979) Advanced stage and early relapse of breast carcinomas associated with high thymidine labeling indices. Cancer Res 39:4042–4047
Meyer JS, Friedman E, McCrate M, Bauer W (1983) Prediction of early course of breast carcinoma by thymidine labeling. Cancer 51:1879–1886
Meyer JS, Bauer WC, Rao BR (1978) Subpopulations of breast carcinoma defined by S-phase fraction, morphology and estrogen receptor content. Lab Invest 39:225–235
Meyer JS, Rao BR, Stevens SC, White WL (1977) Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication. Cancer 40:2290–2298
Meyer JS, Lee LY (1980) Relationships of S-phase fraction of breast carcinoma in relapse to duration of remission, estrogen receptor content, therapeutic responsiveness and duration of survival. Cancer Res 40:1890–1896
Möller P, Mechtersheimer G, Kaufmann M, Moldenhauer G, Momberg F, Mattfeld T, Otto HF (1989) Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast. Virchows Arch [A] 414:157–164
Moran RE, Black MM, Alpert L, Straus MJ (1984) Correlation of cell-cycle kinetics, hormone receptors, histopathology, and nodal status in human breast cancer. Cancer 54:1586–1590
Müller HA, Altenähr E, Böcking A, Dhom G, Faul P, Göttinger H, Helpap B, Hohbach C, Kastendieck H, Leistenschneider W (1980) Über Klassifikation und Grading des Prostatakarzinoms. Verh Dtsch Ges Pathol 64:609–611
Müller-Holzner E, Fend F, Dietze O, Müller LCh, Wiegel J, Mikuz G (1985) DNA-Zytophotometrie und PNA-Inkubation aus Ermittlung prognostischer Faktoren beim Mammakarzinom. Verh Dtsch Ges Pathol 69:544
Parl FF, Wagner RK (1980) The histopathological evaluation of human breast cancers in correlation with estrogen receptor values. Cancer 46:362–367
Parl FF, Schmidt BP, Dupont WD, Wagner RK (1984) Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading. Cancer 54:2237–2242
Rank F, Dombernowsky P, Jespersen NChB, Pedersen EV, Keiding N (1987) Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low-risk carcinomas from a multicenter trial. Cancer 60:1299–1305
Reiner A, Holzner JH, Reiner G, Spona J, Schemper M, Kolb R, Jakesz R (1985) Histologic grading and prognosis in breast cancer. Verh Dtsch Ges Pathol 69:365–369
Reiner A, Kolb R, Reiner G, Jakesz R, Schemper M, Spona J (1987) Prognostic significance of steroid hormone receptors and histological characterization of human breast cancer. J Cancer Res Clin Oncol 113:285–290
Reiner A, Reiner G, Spona J, Schemper M, Holzner JH (1988) Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. Cancer 61:1149–1154
Remvikos Y, Magdelénat H, Zajdela A (1988) DNA flow cytometry applied to fine needle sampling of human breast cancer. Cancer 61:1629–1634
Schenck U, Burger G, Jütting U, Eiermann W (1985) Cellular findings and hormone receptor status — visual and image analytical analysis of breast carcinomas. Verh Dtsch Ges Pathol 69:529–531
Schenck U, Burger G, Jütting U, Eiermann W (1986) Zytomorphologisches Grading und Hormonrezeptorstatus beim Mammakarzinom. Visuelle Untersuchungen an Ausstrichpräparaten. Dtsch med Wschr 111:1949–1953
Silvestrini R, Sanfillipo O, Tedesco G (1974) Kinetics of human mammary carcinomas and their correlation with the cancer and the host characteristics. Cancer 34:1252–1258
Smith R, Crocker J (1988) Evaluation of nucleolar region-associated proteins in breast manignancy. Histopathology 12:113–125
Stiens R, Klotz D (1985) The relation between proliferation and regression in breast with special emphasis on cancer. Verh Dtsch Ges Pathol 69:274–278
Straus MJ, Moran RE, Muller RE, Wotiz HH (1982) Estrogen receptor heterogenity and the relationship between estrogen receptor and the tritiated thymidine labeling index in human breast cancer. Oncology 39:197–200
Tubiana M, Pejovic MH, Chavaudra N, Contesso G, Malaise EP (1984) The long-term prognostic significance of the thymidine labelling index in breast cancer. Int J Cancer 33:441–445
Walker RA (1988) The histopathological evaluation of nucleolar organizer region proteins. Histopathology 12:221–223
Weintraub J, Weintraub D, Redard M, Vassilakos P (1987) Evaluation of estrogen receptors by immunocytochemistry on fine-needle aspiration biopsy specimens from breast tumors. Cancer 60:1163–1172
WHO (1981) Histological typing of breast tumours No 2. Geneva
Wrba F, Chott A, Reiner A, Reiner G, Ritzinger E, Holzner JH (1987) Ki 67-Immunoreaktivität in primären Mammakarzinomen. Eine histochemische Studie. Berichte Pathol 105:246–247
Wrba F, Reiner A, Ritzinger E, Holzner JH, Reiner G (1988) Expression of epidermal growth factor receptors (EGFR) on breast carcinomas in relation to growth factors, estrogen receptors status and morphological criteria. An immunohistochemical study. Pathol Res Pract 183:25–29
Wrba F, Reiner A, Markis-Ritzinger E, Holzner JH, Reiner G, Spona J (1988) Prognostic significance of immunohistochemical parameters in breast carcinomas. Pathol Res Pract 183:277–283
Wyllie AH (1987) Apoptosis: Cell death in tissue regulation. J Pathol 153:313–316
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Helpap, B. Nucleolar grading of breast cancer. Vichows Archiv A Pathol Anat 415, 501–508 (1989). https://doi.org/10.1007/BF00718643
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00718643